Refine by
Healthcare Research Articles & Analysis: Older
104 news found
"We are confident that Semaglutide will have a significant impact on the lives of patients, helping them achieve better glycemic control, weight management, and overall health outcomes," said the senior scientist. "We invite healthcare professionals, researchers, and industry partners to explore the remarkable potential of this innovative peptide and discover how ...
Acinetobacter is described by the Centers for Disease Control and Prevention (CDC) as a group of bacteria commonly found in the environment. While there are many types, the most frequent cause of infections in humans is Acinetobacter baumannii. Infections of the blood, urinary tract, and lungs, or in wounds in other parts of the body can all be caused by Acinetobacter baumannii. It can also ...
CD Formulation's antiserum preparation services cater to a myriad of research and healthcare needs. Their offerings include specialized services in antiviral serum, antibacterial serum, and antitoxin serum preparation. ...
This webinar focuses on the different types of quality control (QC) required for iPSCs, with an emphasis on the International Society for Stem Cell Research (ISSCR) standards guidance. Genomic stability assessment is a crucial part of QC since up to 30 percent of cultures have genomic or genetic changes that can affect downstream usage with significant implications for cell-based ...
Prophecy Market Research says it could reach US$ 508.7 billion by 2034. From data to diagnostics and imaging, drug development and discovery, early intervention and predictive analytics, remote patient monitoring and robotics, AI is revolutionizing healthcare as we know it. Betting on healthcare as a key market, Avant Technologies, Inc. (OTCQB: ...
Laboratory scientists across the world are being invited to have their say in the 2024 Scientists’ Choice Awards®. The annual Scientists’ Choice Awards celebrate the most innovative and effective technologies of the past year and provide scientists worldwide with the opportunity to acknowledge the instruments, assays, tools, or consumables that have made the most difference to ...
The focus industries include healthcare & biomedical sciences, smart cities & urban solutions, trade & connectivity, and emerging sustainable technologies. ...
With its potent bactericidal activity against Gram-positive pathogens, Daptomycin has been a crucial treatment option for healthcare professionals around the world. Daptomycin ReadyMade™ Solution is a sterile filtered solution prepared in a 10% β-cyclodextrin saline solution with a concentration of 1mg/ml. ...
About SeqOne Genomics SeqOne Genomics specializes in high-performance genomic analysis solutions for use in healthcare and life science – hospitals, research institutions, and pharmaceutical companies. ...
Lumosa's Chief Business Officer, Mr. Christopher Aleong will be serving as one of the judges in the Innovator's Pitch Challenge at the RESI (Redefining Early Stage Investments) Conference, on September 21~22, 2022. The Innovator’s Pitch Challenge (IPC) is an opportunity for early-stage life science and healthcare companies to gain additional exposure to conference attendees and pitch ...
Finally, we showed the potential for partnered healthcare system research with EHR integration, in this case for tailored care pathways for diverse ...
Developed by specialists from the medical, technology, and design fields, the platform aims to establish a culture of preventative healthcare in Latvia as well as educate women on breast cancer risks and contraception methods. ...
About DNAnexus DNAnexus is a leading provider of secure, scalable, and intuitive biomedical data analysis software and bioinformatics applications for the life sciences and healthcare communities. The company actively manages and supports more than 65 petabytes of complex genomic, multi-omic, and clinical datasets on behalf of a growing network of collaborations with large-scale ...
He then set up the Grenoble Data Institute, a cross-disciplinary research group, to study how digital technology and data could be harnessed to benefit science and society. ...
Lewis will focus on driving the clinical translation and commercialization of novel technologies arising from cancer research in Alberta. In partnership with Dr. Kinnaird, the two researchers will collaborate to drive world-class prostate cancer research in Alberta with a common goal of supporting research that helps better ...
NEW YORK, Oct. 12, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today provided an update on the status of multiple clinical trials now underway to assess the safety and efficacy of TPOXX to treat monkeypox. In recent weeks, randomized, placebo-controlled clinical trials were initiated in ...
In addition, Bayer will pay research funding and tiered royalties up to low double-digit percentage of net sales. ...
Chris takes up the role of Associate Director of Business Development from KATAOKA-SS America, a laser technology manufacturer specialising in cell processing for areas such as regenerative medicine and drug discovery research, with his prior experience focused on the development of early stage life science companies. Chris established a strong scientific foundation as a ...
Comprising a team of scientist-founders, experienced biopharma veterans, and talented researchers, Mammoth is developing a robust pipeline of novel CRISPR systems capable of providing permanent cures for genetic conditions, and powering next-generation diagnostic tools to enable decentralized disease detection. ...
-based multicenter clinical study for a computer aided polyp detection (CADe) device completed to date, which determined that SKOUT significantly improved overall adenoma detection in screening and surveillance colonoscopy compared to standard colonoscopy.1 In March 2021, Provation and Iterative Scopes entered a partnership focused on delivering artificial intelligence-based solutions to ...